Most oncological microarray studies focus on molecular distinctions in different cancer entities. Recently, researchers started using microarrays for investigating molecular commonalities of multiple cancer types. This poses novel bioinformatics challenges. In this paper we describe a method that detects common molecular mechanisms in different cancer entities. The method extends previously described concepts by introducing Meta-Analysis Pattern Matches. In an analysis of four prognostic cancer studies, involving breast cancer, leukemia, and mesothelioma, we are able to identify 42 genes that show consistent up- or down-regulation in patients with a poor disease outcome. These genes complement the set of previously published candidates for ...
SummaryThe beauty of microarray analysis of gene expression (MAGE) is that it can be used to discove...
Scientists have discovered various prognostic gene signatures (GSs) in different cancer types. Surpr...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
AbstractDiscovering genes involved in multiple types of cancers is of significant therapeutic import...
Microarray technology enables a standardized, objective assessment of oncological diagnosis and prog...
Microarray technology enables a standardized, objective assessment of oncological diagnosis and prog...
Background. Microarray technology enables a standardized, objective assessment of oncological diagno...
© 2011 Dr. Fan ShiModern bioinformatics studies have shown that many physiological and behavioral ch...
Abstract Background Although prognostic biomarkers specific for particular cancers have been discove...
MOTIVATION: Many applications of microarray technology in clinical cancer studies aim at detecting ...
Abstract- Cells are building blocks of living things. Normal cells multiply when body needs them and...
Cancer patients are often overtreated because of a failure to identify low-risk cancer patients. Thu...
SummaryThe beauty of microarray analysis of gene expression (MAGE) is that it can be used to discove...
Scientists have discovered various prognostic gene signatures (GSs) in different cancer types. Surpr...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
AbstractDiscovering genes involved in multiple types of cancers is of significant therapeutic import...
Microarray technology enables a standardized, objective assessment of oncological diagnosis and prog...
Microarray technology enables a standardized, objective assessment of oncological diagnosis and prog...
Background. Microarray technology enables a standardized, objective assessment of oncological diagno...
© 2011 Dr. Fan ShiModern bioinformatics studies have shown that many physiological and behavioral ch...
Abstract Background Although prognostic biomarkers specific for particular cancers have been discove...
MOTIVATION: Many applications of microarray technology in clinical cancer studies aim at detecting ...
Abstract- Cells are building blocks of living things. Normal cells multiply when body needs them and...
Cancer patients are often overtreated because of a failure to identify low-risk cancer patients. Thu...
SummaryThe beauty of microarray analysis of gene expression (MAGE) is that it can be used to discove...
Scientists have discovered various prognostic gene signatures (GSs) in different cancer types. Surpr...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...